Evidence map›Paper›PMID 32620678›Full record

ReviewJournal of clinical pathology2021

Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective.

Lisa Browning, Richard Colling, Emad Rakha, Nasir Rajpoot, Jens Rittscher, Jacqueline A James, Manuel Salto-Tellez, David R J Snead, Clare Verrill

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of clinical pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Clinical and Laboratory Approach to Diagnose COVID-19 Using Machine Learning.Interdisciplinary sciences, computational life sciences · 2022
    Article
  13. Review
  14. Article
  15. Digital pathology and artificial intelligence in translational medicine and clinical practice.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Lisa BrowningCellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID http://orcid.org/0000-0003-4254-333X
Richard CollingNuffield Department of Surgical Sciences, Oxford University, Oxford, Oxfordshire, UK.
Emad RakhaSchool of Medicine, University of Nottingham, Nottingham, Nottinghamshire, UK.
Nasir RajpootTissue Image Analytics Laboratory, Department of Computer Science, University of Warwick, Coventry, West Midlands, UK.
Jens RittscherNIHR Oxford Biomedical Research Centre, Oxford, Oxfordshire, UK.ORCID http://orcid.org/0000-0002-8528-8298
Jacqueline A JamesPrecision Medicine Centre of Excellence, Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Belfast, UK.
Manuel Salto-TellezPrecision Medicine Centre of Excellence, Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Belfast, UK.
David R J SneadDepartment of Pathology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, West Midlands, UK.
Clare VerrillNIHR Oxford Biomedical Research Centre, Oxford, Oxfordshire, UK Clare.Verrill@OUH.nhs.uk.ORCID http://orcid.org/0000-0002-4905-8233
Queen's University Belfast · GBUniversity Hospitals Coventry and Warwickshire NHS Trust · GBUniversity of Oxford · GBJohn Radcliffe Hospital · GBOxford BioMedica (United Kingdom) · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The measures to control the COVID-19 outbreak will likely remain a feature of our working lives until a suitable vaccine or treatment is found. The pandemic has had a substantial impact on clinical services, including cancer pathways. Pathologists are working remotely in many circumstances to protect themselves, colleagues, family members and the delivery of clinical services. The effects of COVID-19 on research and clinical trials have also been significant with changes to protocols, suspensions of studies and redeployment of resources to COVID-19. In this article, we explore the specific impact of COVID-19 on clinical and academic pathology and explore how digital pathology and artificial intelligence can play a key role to safeguarding clinical services and pathology-based research in the current climate and in the future.

Indexed as

Artificial IntelligenceCOVID-19Pathology, ClinicalHumansImage Processing, Computer-AssistedSARS-CoV-2computer systemsimage processing, computer-assistedpathology, surgical

Identifiers

PMID32620678
PMCPMC8223667
OpenAlexW3038687952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.